Drug Shortage Report for BAQSIMI
| Report ID | 239831 |
| Drug Identification Number | 02492415 |
| Brand name | BAQSIMI |
| Common or Proper name | Glucagon Nasal Powder |
| Company Name | AMPHASTAR PHARMACEUTICALS, INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | GLUCAGON |
| Strength(s) | 3MG |
| Dosage form(s) | POWDER |
| Route of administration | NASAL NASAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 3 mg glucagon per device |
| ATC code | H04AA |
| ATC description | GLYCOGENOLYTIC HORMONES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2024-10-10 |
| Actual start date | 2024-10-10 |
| Estimated end date | 2024-10-28 |
| Actual end date | 2024-10-22 |
| Shortage status | Resolved |
| Updated date | 2024-10-23 |
| Company comments | The demands have been higher than the historical trend, and we are in transition period with the switching from Lilly to Amphastar. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11570 SIXTH STREET RANCHO CUCAMONGA, CALIFORNIA UNITED STATES 91730 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2024-10-23 | French | Compare |
| v9 | 2024-10-23 | English | Compare |
| v8 | 2024-10-11 | English | Compare |
| v7 | 2024-10-10 | French | Compare |
| v6 | 2024-10-10 | English | Compare |
| v5 | 2024-10-10 | French | Compare |
| v4 | 2024-10-10 | French | Compare |
| v3 | 2024-10-10 | English | Compare |
| v2 | 2024-10-10 | French | Compare |
| v1 | 2024-10-10 | English | Compare |
Showing 1 to 10 of 10